Welcome to the CancerBio Summer School and Cancer IO Special Sebinar on Hallmarks of Cancer: New Dimensions on 25 May at 13-14 EEST! The event is organised in Zoom and is open to all interested in
Cancer IO’s new report Cancer Immunotherapies in Finland was published in Helsinki University Think Corner on 9 March 2022. The objective of the report is to provide understanding of the current state of the adoption and
Recording of the Cancer IO Sebinar Session IV: ‘Adoptive Cell Therapies’ on 2nd of December 2021is now online!
Welcome to the Cancer IO training “Translating research into clinical benefit” in January 2022!
We are hiring an ambitious and talented Scientific Coordinator to coordinate a large and well-funded breast cancer research program, which aims to translate preclinical laboratory-based breast cancer research to new clinically viable treatment modalities for breast cancer.
Welcome to watch the recording of the Cancer IO Sebinar “Single-cell tumor immunity”.
The report, published on 16 September 2021, describes the hospital preparedness for cancer clinical trials in Finland.
Welcome to the Cancer IO Sebinar Session III: ‘Single-cell tumor immunity’ on 16th of September 2021, 15:00-16:45!
Welcome to watch a recording of our second Sebinar! This time we hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
In this Cancer IO Sebinar Session we will hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
Welcome to the CancerBio Summer School and Cancer IO Special Sebinar on Hallmarks of Cancer: New Dimensions on 25 May at 13-14 EEST! The event is organised in Zoom and is open to all interested in
Cancer IO’s new report Cancer Immunotherapies in Finland was published in Helsinki University Think Corner on 9 March 2022. The objective of the report is to provide understanding of the current state of the adoption and
Recording of the Cancer IO Sebinar Session IV: ‘Adoptive Cell Therapies’ on 2nd of December 2021is now online!
Welcome to the Cancer IO training “Translating research into clinical benefit” in January 2022!
We are hiring an ambitious and talented Scientific Coordinator to coordinate a large and well-funded breast cancer research program, which aims to translate preclinical laboratory-based breast cancer research to new clinically viable treatment modalities for breast cancer.
Welcome to watch the recording of the Cancer IO Sebinar “Single-cell tumor immunity”.
The report, published on 16 September 2021, describes the hospital preparedness for cancer clinical trials in Finland.
Welcome to the Cancer IO Sebinar Session III: ‘Single-cell tumor immunity’ on 16th of September 2021, 15:00-16:45!
Welcome to watch a recording of our second Sebinar! This time we hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
In this Cancer IO Sebinar Session we will hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
cancerio-office@helsinki.fi